These are “exciting times” for patients with axial spondyloarthropathies (axSpA), according to Professor Matthew Brown from the Queensland University of Technology. “The evidence is increasingly strong that we can benefit people’s long-term health and function by treating early with effective medications,” he told the limbic. “Even with existing treatments, we can allow people to lead ...
Exciting times for axial spondyloarthropathy
27 Apr 2017
Sponsored by Janssen-Cilag Pty Ltd